SCHEMBL483688

SCHEMBL483688

O=C1C(c2cc(Br)ccc2O)c2ccccc2N1c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
POLB P06746 1/20 0.38
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
MAPT P10636 3/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
AR P10275 1/20 0.36
HSD17B3 P37058 1/20 0.36
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31717971 0.84 MEN1 (0.41) KDM4ENPSR1ALDH1A1POLBMEN1
SCHEMBL28704414 0.84 COMT (0.40) KDM4EPKMALDH1A1MEN1KMT2A
SCHEMBL28690729 0.74 KDM4E (0.41) KDM4EPKMSMN1; SMN2NPSR1ALDH1A1
SCHEMBL29915861 0.74 MEN1 (0.44) NPSR1ALDH1A1POLBMEN1KMT2A
SCHEMBL208852 0.74 MEN1 (0.44) NPSR1ALDH1A1POLBMEN1KMT2A
SCHEMBL17074881 0.73 MEN1 (0.44) KDM4EPKMSMN1; SMN2NPSR1ALDH1A1
SCHEMBL281760 0.73 SCN9A (0.53) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL28692040 0.72 HDAC4 (0.41) KDM4ESMN1; SMN2NPSR1ALDH1A1POLB
SCHEMBL28703009 0.71 ESR1 (0.35) KDM4EPKMSMN1; SMN2NPSR1ALDH1A1
SCHEMBL28704411 0.70 KDM4E (0.38) KDM4EPKMSMN1; SMN2NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888595-B1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2012-02-01 EP disclosed